In a study that characterized the cellular programs underlying oncogene addiction in AML, MLL-AF9 was shown to be required for expression of the Smyd2 gene, as well as of the oncogenic transcription factors Myb and Myc, albeit the mechanisms underlying Smyd2 regulation remained unclear [7]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.